Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
AssigneeMannKind Corporation
InventorsKeith A. Oberg, Joseph Sulner, Marshall L. Grant
Life of this patent
Estimating the term…
Abstract
Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
Claims16
A method for coating a crystalline microparticle with an active agent in a suspension, the method comprising the following sequential steps:
- (i) dissolving the active agent in a solvent;
- (ii) obtaining a crystalline diketopiperazine microparticle wherein the crystalline diketopiperazine microparticle does not comprise an active agent;
- (iii) forming a suspension comprising the crystalline diketopiperazine microparticle, the active agent, and the solvent;
- (iv) increasing pH of the suspension from about pH 3.0 to between about pH 4.4 and about pH 5;
- (v) adsorbing the active agent onto a surface of the crystalline diketopiperazine microparticle to provide a coating of the active agent on the crystalline diketopiperazine microparticle;
- (vi) removing or exchanging the solvent after step (v).
The method of claim 19, wherein the antibodies to tumor antigens are selected from anti-SSX-241-49, anti-NY-ESO-1, anti-PRAME, anti-PSMA, anti-Melan-A, anti-tyrosinase, and anti-MOPC-21.
Dependencies are inferred from the claim text.